MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202618084069 A) filed by Takeda Pharmaceutical Company Limited on July 08, 2026, for Compositions And Methods Of Cryopreserving Cells.
Inventors include Cao, Lan; Chang, Hui-Hsin; Hu, Jianxin; Shi, Xi; and Nishimoto, Yutaka Filed On.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure provides, among other things, a cryopreservation medium for cryopreserving mammalian cells, the medium comprising: dimethyl sulfoxide (DMSO), disaccharide, human serum, and IL-7 and/or IL-15. The present disclosure also provides, among other things, a cryopreservation medium for cryopreserving mammalian cells, the medium comprising: between about 1 w/v % and 10 w/v % dimethyl sulfoxide (DMSO), between about 0.25 w/v % and 5 w/v % disaccharide, and between about 10 w/v % and 90 w/v % human serum. The present disclosure also provides, among other things, a cryopreservation medium for cryopreserving mammalian cells, the medium comprising: between about 1 w/v % and 10 w/v % dimethyl sulfoxide (DMSO), between about 0.25 w/v % and 5 w/v % disaccharide, and between about 0.5w/v % and 30 w/v % human serum albumin.
Disclaimer: Curated by HT Syndication.
